Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2023-04-26 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2022 Annual Report Summary" of 阳普医疗科技股份有限公司, indicating it is a summary of the full annual report. It contains detailed company information, business overview, product lines, financial data for the year 2022, and shareholder information. The document length is over 10,000 characters, which is substantial and contains actual financial data and analysis. It is not merely an announcement or a certification. The presence of comprehensive financial figures and business descriptions aligns with the characteristics of an Annual Report (10-K). Therefore, the document should be classified as an Annual Report (10-K). FY 2022
2023-04-26 Chinese
独立董事2022年度述职报告（白华）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2022 Annual Report" for Yangpu Medical Technology Co., Ltd. It details the independent director's duties, attendance at board and shareholder meetings, opinions on company matters, committee work, investigations, investor protection efforts, and training during the 2022 fiscal year. The content is a detailed report of the independent director's activities and responsibilities over the year, rather than an announcement or a brief notice. It does not contain financial statements or audit results but focuses on board/management oversight and governance activities. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document length is 2630 characters, which is relatively short but contains substantive content about board member duties and activities, not just a notice or announcement. Therefore, the classification is MANG with high confidence.
2023-04-26 Chinese
公司章程 2023.04
Governance Information Classification · 95% confidence The document is titled as the "Company Articles of Association" (公司章程) for 阳普医疗科技股份有限公司 dated April 2023. It contains detailed provisions about the company's organizational structure, shareholder rights, board and management roles, share issuance and transfer rules, shareholder meeting procedures, voting rights, and other governance matters. There is no financial data, earnings information, audit results, or capital raising updates. The content is focused on the internal rules and governance framework of the company, including shareholder meetings and board structure. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is lengthy and substantive, not a brief announcement or a certification. Therefore, the appropriate classification is CGR with high confidence.
2023-04-26 Chinese
关于召开2022年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of a 2022 annual performance explanation meeting (业绩说明会) by 阳普医疗科技股份有限公司. It references that the 2022 Annual Report has already been disclosed on April 27, 2023, and the meeting is to be held on May 5, 2023, for investor communication and Q&A. The document does not contain the actual financial report or detailed financial data but is an invitation and notice for an investor presentation event. Therefore, it is not the Annual Report itself (10-K) nor an earnings release (ER), but rather an Investor Presentation announcement. Given the nature and content, the best fitting category is Investor Presentation (IP). The document length is short (1001 characters), consistent with an announcement rather than a full report.
2023-04-26 Chinese
关于变更会计政策的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from 阳普医疗科技股份有限公司 regarding changes in accounting policies in response to new accounting standards issued by the Ministry of Finance of the People's Republic of China. It details the reasons for the changes, the dates of implementation, and the impact on the company’s financial statements. The document is relatively short (1129 characters) and does not contain actual financial statements or detailed financial data. It is a formal announcement about accounting policy changes rather than a full audit report or annual/interim report. Therefore, it fits best under Audit Report / Information (AR), which covers standalone audit reports, applied accounting principles, and related accounting policy changes, excluding full annual reports. FY 2023
2023-04-26 Chinese
关于拟续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (audit firm) for the company's 2023 annual audit. It details the background, qualifications, and integrity of the audit firm and the audit team, as well as the approval process by the board, audit committee, independent directors, and supervisory board. It does not contain any actual audit report, financial statements, or audit results. The document is relatively short (3214 characters) and serves as a formal announcement of the intention to reappoint the auditor, pending shareholder approval. Therefore, it is not the audit report itself but an announcement related to audit services. According to the classification rules, such announcements about audit firm appointments or reappointments fall under Regulatory Filings (RNS) as they do not contain the audit report or financial data themselves.
2023-04-26 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.